Strongyloides stercoralis hyperinfection with shock and thrombosis
- Darío Sebastián López-Delgado,
- Carlos A. Narváez,
- Roberto Bonfante-Villalobos,
- Joshua Emmanuel Arteaga,
- Hector Fabio Sanchez-Galvez,
- Yamile Jurado
- Universidad Cooperativa de Colombia,
- Universidad Nacional Autónoma de Nicaragua, Managua,
- Hospital Universitario Departamental de Nariño,
- ,
- Fundacion Universitaria Autonoma de las Américas
Open access
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 233-238 (6 pages)Journal (Volume, Issue Number)
Infezioni in Medicina (Volume 33, Issue 2)Publication milestones
- Published - 2025
Publication status
ISSN
1124-9390Publication IDs
- Scopus: 105007561968
Abstract
Strongyloides stercoralis (SS) is an intestinal parasite that can cause chronic asymptomatic infections, but in rare cases, it can progress to hyperinfection syndrome (SHS). This report describes a case of SHS associated with deep vein thrombosis and pulmonary thromboembolism, a rare manifestation in an immunocompetent patient. A 19-year-old female patient with a 15-day history of abdominal pain, progressive edema of the lower limbs, hemoptotic cough, asthenia, and weight loss. During her hospitalization, she developed sudden dyspnea, desaturation, and distributive shock, requiring invasive mechanical ventilation. Pulmonary angiotomography showed pulmonary thromboembolism, and deep vein thrombosis was diagnosed. Bronchoscopy revealed alveolar hemorrhage, while bronchoalveolar and duodenal lavage confirmed the presence of SS. Ivermectin and albendazole were started with full-dose anticoagulation for the thrombotic event. After one week of management, bronchoalveolar lavage results were negative, and the patient showed significant improvement with no long-term complications. SHS is rare in immunocompetent patients, and its association with thrombosis has been poorly documented in the literature. This case emphasizes the importance of early diagnosis and timely management to avoid life-threatening complications. It also highlights the need for surveillance in endemic regions and the appropriate use of evidence-based therapeutic strategies.
Access to documents
Sustainable Development Goals
- SDG 3 Good Health and Well
